ITxM The Institute for Transfusion Medicine

Date	Title	Author
Nov./Dec. 1999	RECOMBINANT FACTOR VIIa: A New Product for Factor VIII and IX Inhibitors	Margaret V. Ragni, M.D., Medical Director, M.P.H., Director, Hemophilia Center of Western Pennsylvania Patient Transfusion Services
October 1999	Elective Surgery, Preadmission Testing, and The Transfusion Service	Ileana Lopez-Plaza, M.D., Associate Medical Director, Transfusion Services
September 1999	Platelet Transfusion Therapy	Valerie Lyons, M.D., Fellow Darrell J. Triulzi, M.D., Medical Director, Patient Transfusion Services
June/July 1999	Cord Blood Banking and Transplantation	Richard Moldwin, MD, Ph.D. Medical Director ITxM Cord Blood Services
May 1999	Nucleic Acid Amplification Testing	Arell Shapiro, M.D., LifeSource Blood Services
April 1999	Update on the Risk of Viral Infection from a Blood Transfusion in the Tri-State Area	Leo Manack, M.D., Fellow in Transfusion Medicine Joseph Kiss, M.D., Medical Director, Hemapheresis and Blood Services
March 1999	Disseminated Intravascular Coagulation	Agnes Aysola, M.D., ITxM Fellow Ileana Lopez-Plaza, M.D., Assistant Medical Director, CTS
February 1999	Laboratory Monitoring of Anticoagulant Therapy	Andrea Cortese Hassett,Ph.D.
January 1999	Plasma Alternatives Update (Updated from November 1997)	Darrell J. Triulzi, M.D.
November / December 1998	Cruetzfeldt Jakob Disease (CJD) and Blood	Arell Shapiro, M.D.
October 1998	Thrombotic Thrombocytopenic Purpura Syndrome	Valerie A. Lyons, M.D., Resident in Pathology Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services
August / September 1998	Acquired Inhibitors to Factor VIII	Margaret Ragni, M.D.
July 1998	Hepatitis C Virus Lookback	Arell Shapiro, M.D.
June 1998	The Prothrombin Variant	Franklin A. Bontempo, M.D.
May 1998	Maximizing the Effectiveness of Preoperative Autologous Blood donations (PABD)	Joseph E. Kiss, M.D.
April 1998	Massive Blood Transfusion	Ileana Lopez-Plaza, M.D.
February/March 1998	Optimizing the INR to Improve Oral Anticoagulant Monitoring	Andrea Cortese Hassett, Ph.D.
December 1997 / January 1998	New Anticoagulants	Franklin A. Bontempo, M.D.
November 1997	Plasma Alternatives	Darrell J. Triulzi, M.D.
September / October 1997	Red Cell Transfusion Therapy	Ileana Lopez-Plaza, M.D.
August 1997	Hereditary Hemachromatosis	Andrea Cortese Hassett, Ph.D. Joseph E. Kiss, M.D.
June / July 1997	Optimizing Platelet Transfusion Therapy	Darrell Triulzi, M.D.
May 1997	LDL APHERESIS: A New Treatment For Severe Dyslipidemia	Rama Shankar, M.D. Joseph E. Kiss, M.D.
April 1997	HIV Postexposure Prophylaxis	Margaret Ragni, M.D.
March 1997	Use and Abuse of Fresh Frozen Plasma	Darrell J. Triulzi. M.D.
February 1997	Granulocyte Transfusion	Donald L. Kelley, M.D. Ileana Lopez-Plaza, M.D
January 1997	Heparin-Induced Thrombocytopenia	Franklin A. Bontempo, M.D.
October 1996	New Concepts in Drug-induced Hemolytic Anemias	Donald Kelley, M.D. Darrell J. Triulzi, M.D., Medical Director
September 1996	The Donor / Demand Dilemma	Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services
June 1996	Low Molecular Weight Heparin	Franklin A. Bontempo, M.D. Medical Director Andrea Cortese Hassett, Ph.D., Scientific Director, Coagulation Laboratory
May 1996	Immune Mediated Hemolytic Disease Of The Newborn	Ileana Lopez-Plaza, M.D., Assistant Medical Director of Transfusion Services
April 1996	The Human Parovirus B19 In Transfusion Medicine	Beatrice J. Tiangco, M.D., Fellow Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services
February 1996	Heparin Monitoring	Andrea Cortese Hassett, Ph.D.
January 1996	Neonatal Alloimmune Thrombcytopenia	Ileana Lopez-Plaza, M.D.
December 1995	A New Blood Donor Screening Test To Further Improve Blood Safety: HIV-1 P24 Antigen	Arrell Shapiro, M.D. Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services
October 1995	Autologous And Directed Blood Donations	Joseph Kiss, M.D., Medical Director, Hemapheresis and Blood Services
September 1995	Intravenous (HUMAN) Rho(D) Immune Globulin	Katherine A. Anderegg, M.D. Darrell J. Triulzi, M.D., Medical Director
August 1995	The Factor V Leiden Mutation	Franklin A. Bontempo, M.D., Medical Director, Coagulation Services Andrea Cortese Hassett, Ph.D., Scientific Director, Coagulation Services
July 1995	Erythropoeitin	Hawazin Faruki, Dr.P.H. Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services
June 1995	The INR (International Normalized Ratio) For Monitoring Oral Anticoagulant Therapy	Andrea Cortese Hassett, Ph.D., Scientific Director, Coagulation Services Frank A. Bontempo, M.D., Medical Director, Coagulation Services
May 1995	Hematopoietic Stem Cell Transplants	Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services Darrell J. Triulzi, M.D., Medical Director
March 1995	Cryoprecipitate Component Characteristics	Ileana Lopez-Plaza, M.D., Associate Medical Director, Centralized Transfusion Service
February 1995	The Risk Of Viral Infection From A Blood Transfusion In The Tri-State Region	Katherine A. Anderegg, M.D., Transfusion Medicine Fellow Joseph E. Kiss, M.D., Medical Director, Hemapheresis and Blood Services
January 1995	Plasma Transfusion Therapy	Darrell J. Triulzi, M.D., Medical Director, Centralized Transfusion Services
November 1994	The Activated Protein C Resistance Test	Franklin A. Bontempo, M.D., Medical Director, Coagulation Services Andrea Cortese Hassett, Ph.D., Scientific Director, Coagulation Services
October 1994	von Willebrand Disease	Margaret V. Ragni, M.D., M.P.H., Medical Director, Hemophilia Center of Western Pennsylvania
September 1994	HIV Therapy Monitoring	Hawazin Faruki, Dr.P.H. Scientific Director, Molecular Diagnostics Reference Laboratory
August 1994	Transfusion Transmitted Cytomegalovirus	Darrell J. Triulzi, M.D., Medical Director
July 1994	Taking the Next Step in Blood Transfusion Safety: Viral Inactivation of Plasma and Plasma Products	Joseph E. Kiss, M.D. Medical Director, Central Blood Bank, Hemapheresis and Blood Services
May 1994	Hepatitis B Vaccination	Alan Winkelstein, M.D.
April 1994	Use and Misuse of the Bleeding Time	Franklin A. Bontempo, M.D.
March 1994	Enterically Transmitted Viral Hepatitis	Oliver Kimka Ndimbie, M.D.
January 1994	Indirect and Direct Antiglobulin (Coombs) Testing	Darrell J. Triulzi, M.D., Medical Director, Patient Transfusion Services
December 1993	The Safety of Blood	Alan Winkelstein, M.D.
November 1993	Flow Cytometry	Alan Winkelstein Medical Director
October 1993	New Diagnostics for Hepatitis C Virus	Hawazin Faruki, Dr.P.H., Scientific Director
September 1993	Peripheral Blood Stem Cell Transplantation	Joseph E. Kiss, M.D. Medical Director Apheresis/Outpatient Services
July 1993	Intravenous Gamma Globulin	Alan Winkelstein, M.D. Medical Director
June 1993	HEPATITIS B VIRUS: Testing and Disease Monitoring	Oliver Kimka Ndimbie,M.D., Medical Director Viral Testing, HLA, and Molecular Diagnostics Laboratories
May 1993	Leukocyte-reduced Transfusion Therapy	Joseph E. Kiss, M.D., Medical Director, Blood Program and Apheresis/Outpatient Services
April 1993	HIV and Hemophilia	Margaret V. Ragni, M.D., Director Hemophilia Center Of Western Pennsylvania
January 1993	Polymerase Chain Reaction and Its Clinical Applications to Blood Banking	Hawazin Faruki, Dr.P.H. Director Molecular Diagnostics Reference Laboratory and Alan Winkelstein, M.D. Medical Director
December 1992	The Lupus Anticoagulant	Franklin A. Bontempo, M.D., Medical Director, Coagulation Services
November 1992	Newer Approaches to Treatment of Hemophilia and von Willebrand's Disease	Margaret V. Ragni, M.D. Director, Hemophilia Center Of Western Pennsylvania
September 1992	Transfusion Associated Graft vs. Host Disease and Irradiated Blood Products	Hawazin Faruki, Dr.P.H., Scientific Director
August 1992	Fresh Frozen Plasma	Franklin A. Bontempo, M.D. Associate Medical Director Coagulation Services
July 1992	Use of Topical Fibrinogen	Darrell J. Triulzi, M.D. Assistant Medical Director, Patient Transfusion Services
June 1992	Autologous and Directed Donations	Joseph E. Kiss, M.D., Associate Medical Director
April 1992	Accidental Exposure Program for Blood-Borne Pathogens	Alan Winkelstein, M.D. Medical Director
February 1992	Hepatic C Virus	Oliver Kimka Ndimbie, M.D. Medical Director Patient Viral Testing

Peripheral Blood Stem Cell Transplantation

Fresh Frozen Plasma